Contract award · 20 Jan 2026

Support of existing Low Density Lipid (LDL) Removal Apheresis Systems

NHS Blood and Transplant awarded “Support of existing Low Density Lipid (LDL) Removal Apheresis Systems” to Fresenius Medical Care (UK) Limited for £338k.

Repair & maintenanceSouth West

Competition with a shortlist

Competitive procedure with a selection stage: suppliers were shortlisted before being invited to bid.

Key facts

Buyer
NHS Blood and Transplant · Body governed by public law
Value
£337,798.08
Procedure
Call-off from a framework agreement
Sector
Repair & maintenance · Repair and maintenance services of medical and surgical equipment (CPV 50420000)
Timeline
  1. Contract date20 Jan 2026
  2. Published18 Feb 2026Published 29 days after the contract date

Description

NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales. Requirement for support of existing Low Density Lipid (LDL) Removal Apheresis Systems.

About the supplier

More from NHS Blood and Transplant

All contracts

More won by Fresenius Medical Care (UK) Limited

All contracts

Recent repair & maintenance contracts

Sector overview